Weight Loss and Obesity Management Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


The global Weight Loss and Obesity Management Market is estimated to be valued at US$ 225.66 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. 

Market Overview: 

The weight loss and obesity management market comprises products such as diets, meals, nutraceuticals, surgical and non-surgical devices that help in reducing excess body weight and managing obesity. These products help in reducing fat deposits and managing overall weight in a healthy and effective manner.

Market key trends:

The nutraceuticals segment is witnessing highest growth within the weight loss and obesity management market owing to increasing awareness about health benefits of foods with added nutrition. Nutraceuticals provide nutrients along with additional health benefits and help in weight management by increasing metabolism and energy levels. The segment growth is also driven by the introduction of new plant-based and organic nutraceutical products targeting at specific weight management needs such as fat burning, appetite suppression etc. The nutraceuticals are available in various forms such as pills, powders, gummies and are rich in fibers, proteins and other essential vitamins and minerals thereby driving their demand.

Read More Insights: https://www.coherentmarketinsights.com/market-insight/weight-loss-and-obesity-management-market-3448

Segment Analysis

The global weight loss and obesity management market is dominated by the dieting segment. Dieting accounts for over 30% of the total market share owing to the preference of non-invasive and easy to adopt methods for losing weight. Dieting involves restricting calorie intake and changes in eating patterns to induce weight loss. The dominance of the dieting segment can be attributed to the ease of use and adoption as compared to other methods requiring medical interventions or procedures. 

Key Takeaways

The global weight loss and obesity management market is expected to witness high growth, exhibiting a CAGR of 7.9% over the forecast period, due to increasing prevalence of obesity worldwide owing to sedentary lifestyle and consumption of junk food. 

Regional analysis: North America dominates the global market currently, owing to growing obesity rates and awareness regarding weight loss management. Asia Pacific is expected to witness the fastest growth over the forecast period supported by improving healthcare infrastructure and expanding medical tourism industry in the region.

Key players: Key players operating in the weight loss and obesity management market are Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Herbalife International of America, Inc., F. Hoffmann-La Roche Ltd, VIVUS LLC., Apollo Endosurgery, Inc. Novo Nordisk A/S dominates the market owing to its strong product portfolio and global brand presence.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

Breast Pumps Market to Surpass US$ 1,211.6 Million with a CAGR of 4.6% by 2027

-
Image
A breast pump is a mechanical tool used by breastfeeding women to suction-extract their breast milk, which they then use to feed their newborn children. Both manually and electrically driven breast pumping equipment is available. Breast pumps are advantageous for working women, women with shorter gestational periods, and women who give birth to multiples since they are unable to simultaneously breastfeed all of the babies, therefore they prefer a breast pump. Breast pumps aid in meeting the nutritional needs of babies of working mothers who do not want to sacrifice their development and growth since they are not constantly present with their infants. Business Dynamics Launches of breast pumps by leading industry players are anticipated to fuel the market's expansion throughout the forecast period. For instance, Sonata, the first smart breast pump to give hospital-level performance in a personal use breast pump, was introduced by Madela, Inc. in November 2016. This breast pump conn...
Read more

Angioedema Treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2024 To 2031

-
Image
Introduction: Angioedema, a condition characterized by rapid swelling of deeper layers of the skin and mucous membranes, poses a significant health concern for affected individuals. The Angioedema Treatment Market has been witnessing notable advancements, providing a ray of hope for patients grappling with this often unpredictable and potentially life-threatening condition. Market Dynamics: The Angioedema Treatment Market has experienced a paradigm shift in recent years, driven by increased awareness, improved diagnostic capabilities, and a surge in research and development efforts. Angioedema can be hereditary or acquired, and the market is witnessing a growing prevalence of both forms, necessitating a diversified approach to treatment options. Treatment Modalities: Therapeutic approaches to Angioedema have evolved, offering a range of options for patients. Antihistamines and corticosteroids are commonly prescribed for acute cases, providing relief from swelling and discomfort. In mor...
Read more